Postmarket safety events common after FDA approval

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1652卷 / 1期
关键词：
D O I：
10.1007/s40278-017-30148-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [41] FDA Approval for Rectiv
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (08) : 939 - 939
  • [42] FDA approval likely
    不详
    [J]. EUROPEAN CHEMICAL NEWS, 1996, 66 (1741): : 52 - 52
  • [43] THE FDA APPROVAL PROCESS
    HOKE, F
    [J]. SCIENTIST, 1994, 8 (18): : 6 - 6
  • [44] Assessing patients' access to tetrabenazine (xenazine) after FDA approval
    Palao, A. M.
    Mostile, G.
    Hunter, C. B.
    Jankovic, J.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S275 - S275
  • [45] Integration of new technology into clinical practice after FDA approval
    Govil, Ashul
    Hao, Steven C.
    [J]. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2016, 47 (01) : 19 - 27
  • [46] Patients' perspective of tetrabenazine 2 years after FDA approval
    Palao, A. M.
    Hunter, C. B.
    Jankovic, J. J.
    [J]. MOVEMENT DISORDERS, 2011, 26 : S259 - S259
  • [47] Integration of new technology into clinical practice after FDA approval
    Ashul Govil
    Steven C. Hao
    [J]. Journal of Interventional Cardiac Electrophysiology, 2016, 47 : 19 - 27
  • [48] Belimumab: Where Are We Three Years After FDA Approval?
    Daniel J. Wallace
    [J]. Current Treatment Options in Rheumatology, 2015, 1 (1) : 42 - 50
  • [49] Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings
    Solotke, Michael T.
    Ross, Joseph S.
    Shah, Nilay D.
    Karaca-Mandic, Pinar
    Dhruva, Sanket S.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (11): : 1201 - +
  • [50] Assessing the Safety and Effectiveness of Devices After US Food and Drug Administration Approval FDA-Mandated Postapproval Studies
    Reynolds, Ian S.
    Rising, Joshua P.
    Coukell, Allan J.
    Paulson, Kirsten H.
    Redberg, Rita F.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (11) : 1773 - 1779
12345